Drupal.behaviors.print = function(context) {window.print();window.close();}>
Silence Inks Tech-Evaluation Deal with Miragen
January 12, 2012
Silence Inks Tech-Evaluation Deal with Miragen
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
InteRNA Technologies, Silence Therapeutics to Co-Develop miRNA Cancer Drugs
September 15, 2011 / Gene Silencing News
MiRagen Hits First Milestone in Servier microRNA Drug Partnership
May 23, 2013 / Gene Silencing News
Miragen Licenses miR-145 IP from University of Glasgow
March 7, 2013 / Gene Silencing News
IP Update: Recent Patents, Patent Applications Awarded to CalTech, Alnylam, Silence, and More
January 24, 2013 / Gene Silencing News
Silence Inks Delivery Tech Evaluation Deal with Mireven
August 23, 2012 / Gene Silencing News